BIOFARM S.A.
Research BIOFARM S.A. (BIO.RO) on Bullrun: market cap RON 1.35B, P/E 19.6, dividend yield 13.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIO.RO
- ExchangeRO
- CountryRomania
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyRON
- Market capRON 1.35B
- P/E19.6
- Dividend yield13.3%
- Financial periodQ2 2026
- RevenueRON 45.34M
- Net income-RON 6.10M
- Free cash flowRON 12.84M
- Gross margin95.4%
Valuation Snapshot
latest market cap is RON 1.35B; P/E is 19.6; dividend yield is 13.3%.
Peer valuation comparison
Latest P/E is 19.57x versus a Healthcare sector median of 24.6x (20.4% below).
Latest dividend yield is 13.3% versus a Healthcare sector median of 1.84% (622.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | RON 1.35B | 19.6 | 3.1% | 0.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.04 RON, yield 13.3%.
About BIOFARM S.A.
Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BIOFARM S.A.'s market cap?
BIOFARM S.A.'s market capitalization is RON 1.35B.
What is BIOFARM S.A.'s P/E ratio?
BIOFARM S.A.'s price-to-earnings (P/E) ratio is 19.6.
Does BIOFARM S.A. pay a dividend?
BIOFARM S.A. has a dividend yield of 13.3%.
What does BIOFARM S.A. do?
Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works.